Intestinotrophic glucagon-like peptide-2 analogs
US6184201A · kind A · utility
87Cited by
16References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 1997 |
| Grant date | Feb 6, 2001 |
| Priority date | — |
| Expiry date | Apr 8, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.